TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Sep 14, 2023 14:45 JST
Source:
Mitsubishi Heavy Industries (MHI)
MHI Becomes a Full Member of the Japan Center for Engagement and Remedy on Business and Human Rights (JaCER)
-- Efforts to Respect the Human Rights of all Stakeholders will be Strengthened through the Engagement and Remedy Platform --
- Efforts to respect the human rights of all stakeholders, including those in the supply chain, will be strengthened
TOKYO, Sep 14, 2023 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) has become a full member of the Japan Center for Engagement and Remedy on Business and Human Rights (JaCER) and started utilizing the Engagement and Remedy Platform provided and operated by JaCER.
JaCER supports its member companies in redressing grievances related to human rights in a professional capacity through its Engagement and Remedy Platform, a non-judicial platform based on the UN Guiding Principles on Business and Human Rights. As globalization has accelerated in recent years, companies are increasingly expected by the international community to manage their operations in a manner that respects the human rights of all stakeholders.
The UN Guiding Principles require companies to address three main elements: policy commitment, human rights due diligence, and processes to enable the remediation of any adverse human rights impacts (grievance mechanisms). The MHI Group Human Rights Policy was established in 2021 to clarify the MHI Group's stance on human rights when conducting business activities in countries and regions around the world. This policy pledges to respect human rights in the MHI Group, following the MHI Group Global Code of Conduct. In line with this Policy, the Group will strive to fulfill its responsibilities in important areas related to human rights.
Furthermore, the Human Rights Due Diligence Task Force, which was established under the Sustainability Committee in fiscal 2021, have reviewed how to proceed with human rights due diligence. Human Rights Due Diligence Liaison Meeting, established in fiscal 2022, shares the status of due diligence efforts with relevant internal divisions, including business divisions, and discusses future measures.
And MHI Group have been conducting due diligence since fiscal 2022 with a focus on suppliers in high-risk areas.
To date, the MHI Group has operated various internal and external grievance mechanisms such as a customer support hotline, whistleblowing hotline and harassment consultation helplines. With the Engagement and Remedy Platform provided by JaCER, a system has been put in place to respond both to consultation from all stakeholders, including those in the supply chain, and to knowledge shared by third parties, and in doing so, strengthen efforts to respect human rights in response to the demands of the international community, including the UN Guiding Principles.
MHI conducts corporate management that respects business and human rights by utilizing JaCER's Engagement and Remedy Platform as a third-party service to receive human rights-related consultation from all stakeholders in a timely manner, and by implementing appropriate responses to the consultation received in a fair and transparent manner.
Japan Center for Engagement and Remedy on Business and Human Rights (JaCER):
https://jacer-bhr.org/en/index.html
MHI Group Human Rights Policy: www.mhi.com/sustainability/social/pdf/mhigroup_human_rights_policy.pdf
About MHI Group
Mitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com.
Source: Mitsubishi Heavy Industries (MHI)
Sectors: Energy, Alternatives
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
MHI Demonstrates Energy Efficiency Improvements through Cooling Optimization in Operational Data Center
July 13 2026 22:00 JST
MHI Receives Order from Taiwan High Speed Rail Corporation for Maintenance Tools and Equipment for Yanchao Main Workshop
July 02 2026 23:22 JST
MHIEC Completes Rebuild of Nagasaki City East Plant
June 30 2026 22:04 JST
Mitsubishi Shipbuilding Receives Order for the MAmmoSS(R) Ammonia Fuel Handling System
June 27 2026 12:16 JST
MHI Study Results Indicate Potential Cost Reductions in the Decarbonization Value Chain Using Green Hydrogen and Ammonia Produced in India
June 27 2026 12:00 JST
MHIET's 500kW-Class Hydrogen Engine Generator Set Achieves Technology Readiness Level for Commercialization
June 24 2026 01:29 JST
Collaboration Between OCTARVIA Programs and MiPoLin(R)
June 08 2026 22:34 JST
Operations Started for the Nagaoka Methanation Demonstration Utilizing the CO2NNEX(R) Digital Platform for Transfer and Management of e-Methane Clean Gas Certificates
June 04 2026 22:49 JST
Mitsubishi Heavy Industries and Preferred Networks Form Business Alliance to Jointly Develop Japan-Made AI Technologies for Mission-Critical Applications
June 03 2026 22:51 JST
JAL Engineering and Mitsubishi Heavy Industries Establish Joint Venture "Aero Breath" for Aircraft Aftermarket Business
June 03 2026 22:27 JST
More Press release >>
Latest Press Release
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship
Jul 17, 2026 10:00 JST
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities
Jul 16, 2026 22:00 JST
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Jul 16, 2026 00:18 JST
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Jul 15, 2026 23:51 JST
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026
Jul 15, 2026 23:21 JST
NEC develops world's first proprietary-AI technology to rapidly generate highly detailed 3D models solely from general-purpose camera footage while automatically removing unnecessary subjects
Jul 15, 2026 22:53 JST
Hitachi Rail achieves EcoVadis platinum medal, ranking among the top 1% of companies worldwide for sustainability performance
Jul 15, 2026 22:35 JST
Anime Tokyo Station Reaches 300,000 Visitors!
Jul 15, 2026 11:00 JST
Fujitsu launches AI-driven modernization service to accelerate legacy system transformation
Jul 14, 2026 19:12 JST
Anime Tokyo Station: TV Anime "BLEACH: THE BLOOD WARFARE - The Calamity" Special Exhibition
Jul 14, 2026 11:00 JST
JCB Signs Memorandum of Understanding with Circle to Explore Collaboration Utilizing Stablecoins
Jul 14, 2026 10:00 JST
Mitsubishi Power Receives Contract to Supply Boilers for Fuel Conversion Work at Existing Thermal Power Plants in Saudi Arabia
Jul 14, 2026 00:58 JST
Fujitsu developed an AI Agent to collaborate with store managers for AEON Food Style's strategic store operations
Jul 14, 2026 00:38 JST
LEQEMBI(R) Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference(R) (AAIC(R)) 2026
Jul 14, 2026 00:06 JST
Hitachi Digital Services announces partnership with ServiceNow to advance AI-powered solution for mission-critical infrastructure monitoring
Jul 13, 2026 23:35 JST
MHI Demonstrates Energy Efficiency Improvements through Cooling Optimization in Operational Data Center
Jul 13, 2026 23:00 JST
Mitsubishi Motors and Highlanders Sign MOU to Establish a New Industrial Foundation Where Humans and Robots Work Together
Jul 13, 2026 22:24 JST
Aflac Life Insurance Japan and The Cancer Institute Hospital of JFCR adopt Fujitsu's Medical Certificate Integration Service for online claim completion
Jul 13, 2026 21:56 JST
JCB, Resona and ODAWARA MOU to Advance Hands-Free UWB Payments for a Next-Generation Bus Experience
Jul 09, 2026 10:00 JST
MUFG Bank and JCB Sign MOU for Comprehensive Strategic Alliance in ASEAN
Jul 06, 2026 13:30 JST
More Latest Release >>